BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 12286973)

  • 21. Post coital contraception.
    Haspels AA; Van Santen MR
    J Gynaecol Endocrinol; 1986; 2(1-2):17-24. PubMed ID: 12269214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Contraception for the diabetic woman].
    Arlot S; Mesmacque A; Lalau JD; Quichaud J
    Fertil Contracept Sex; 1988 Nov; 16(11):921-6. PubMed ID: 12282829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Desogestrel-ethinylestradiol, an oral monophasic contraceptive. Clinical and lipid metabolic effects: a 5-year experience.
    Rubio-lotvin B; Ruiz-moreno JA; Gonzalez-ansorena R
    Adv Contracept Deliv Syst; 1992; 8(1-2):75-88. PubMed ID: 12285566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Progestins and arterial disease].
    Rozenbaum H
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):344-52. PubMed ID: 12280205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exercise and "the pill": putting a rumor to rest.
    Schelkun PH
    Phys Sportsmed; 1991 Mar; 19(3):143-4, 146, 151-. PubMed ID: 12286895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic effects of oral contraceptives: fact vs. fiction.
    Contracept Rep; 1996 Jan; 6(6):4-14. PubMed ID: 12320011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Duration of lactation and return of menstruation in lactating women using hormonal contraception and IUDs.
    Prema K
    Contracept Deliv Syst; 1982 Jan; 3(1):39-46. PubMed ID: 12264126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IPPF statement on oral contraceptives and cancer of the breast.
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1989 Apr; 23(2):4. PubMed ID: 12342374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The myth about contraceptives and breast cancer.
    Ibekwe J
    Dly Times; 1993 Mar; ():7. PubMed ID: 12179509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of the phase of the menstrual cycle and the birth control pill on athletic performance.
    Lebrun CM
    Clin Sports Med; 1994 Apr; 13(2):419-41. PubMed ID: 8013042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Oral contraceptives and blood platelets].
    Davenas E; Ciavatti M; Poitevin B; Aubin M
    Homeopath Fr; 1985; 73(5):299-305. PubMed ID: 12281246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A comparative clinical study of the effects of three types of low-dose estrogen/progestogen oral contraceptives].
    Chen JK
    Shengzhi Yu Biyun; 1987 May; 7(2):11-6. PubMed ID: 12268918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NORPLANT contraceptive implants advancing.
    Segal SJ
    Netw Res Triangle Park N C; 1984; 5(3):1-3. PubMed ID: 12279797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Macroprogestative contraception: advantages].
    Jamin C
    Contracept Fertil Sex (Paris); 1993 Feb; 21(2):123-8. PubMed ID: 12318009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Progestogen contraception using chlormadinone acetate in women presenting high vascular risk. (A gynecoendocrine, metabolic and vascular study).
    Pelissier C; Basdevant A; Conard J; Egloff M; Husson T; Guyenne TT
    Contracept Fertil Sex (Paris); 1987 Jan; 15(1):45-54. PubMed ID: 12315161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Oral contraception: disadvantages of estrogen reduction].
    Denis C
    Contracept Fertil Sex (Paris); 1993 Jun; 21(6):481-8. PubMed ID: 12318238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cardiovascular risks of oral contraceptives: dose-response relationship].
    Kelleher CC
    Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Metabolic risks of oral contraception].
    Monier L
    Rev Int Pediatr; 1988 Feb; (178):64-5. PubMed ID: 12282576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Contraception without risk of breast disease: epidemiologic and physiopathologic arguments].
    Le Coutour X
    NPN Med; 1985 Apr; 5(88):471-6. PubMed ID: 12315304
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.